|
News Briefs

Media Releases

Conferences
Photo Library
|
27.01.2004
There have been numerous reports over recent years confirming a valuable role for aspirin in certain cancers.
From time to time there are reports representing a different view. The recent analysis of data from a major review of womens' health suggested that prolonged use of aspirin caused an increase in the risk of very rare cancer of the pancreas.
Commenting on this data, Dr. Richard Sullivan, Head of the Clinical Program at Cancer Research UK, said 'compared to the risk of developing pancreatic cancer due to smoking, excessive alcohol and weight gain, the risk presented by aspirin is negligible.'
At a recent conference in London Dr Sullivan also said 'chemo prevention strategies may prove to be a very important tool in preventing cancer and a number of studies have demonstrated aspirin's potential utility in preventing a range of cancers.'
|
|
|
|